GAN-OBS

presented by
Devices & Diagnostics

Blood glucose technologies company Glytec raises $8.2M

Glytec, a company whose technology helps diabetics monitor and manage their blood glucose levels, has raised $8.27 million in equity financing that the company will use to support growth in the United States and abroad, as well as for continued research and development. According to securities filings, the glycemic  management systems company’s parent targeted the […]

presented by
MedCity Influencers

Walking Your Way to Better Health

A path to better health and wellness can be as easy as putting one foot in front of the other. That is one of the ideas behind the innovative and creative “Walk with a Doc” program created by Ohio State Medical Association (OSMA) member David Sabgir, MD, a Columbus cardiologist. The program encourages increased healthy […]

Pharma

Takeda, Furiex try again in a post-Avandia diabetes drug world

A type 2 diabetes drug hopefully thought of as a potential blockbuster before stalling amid safety concerns is now taking another shot at approval. Takeda Pharmaceuticals (TYO:4502), which is partnered with Morrisville, North Carolina-based Furiex Pharmaceuticals (NASDAQ:FURX) on the diabetes drug candidate alogliptin, has filed two new drug applications  for the compound with the U.S. […]

presented by
Pharma

Minnesota diabetes startup Exsulin seeks $25 million

Minnesota diabetes startup Exsulin, which is developing a drug to treat Type I diabetes, is trying to raise $25 million to help fund a large clinical trial next year. CEO and co-founder Lisa Jansa, who has been slowly building the Burnsville company, said that Exsulin is looking to raise money from research universities that may be […]